Mary Nelson, PA
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (58.6%), travel and lodging and education — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Intuitive Surgical at 41.9% of the total. 2025 is the largest year on record at $2,478, more than ten times the $13 reported in 2021.
Across 136 payments — averaging $36.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$2K
- Johnson & Johnson$599
- AbbVie$529
- Takeda Pharmaceuticals U.S.A., Inc.$239
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$238
- Lilly USA, LLC$229
- plus $1K from 14 others
What the payments were for
- Travel & lodging$1,84637%
- Food & beverage$2,90159%
- Education$2004%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 13 | $2,075 |
| Johnson & Johnson | 24 | $599 |
| AbbVie | 19 | $529 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $239 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $238 |
| Lilly USA, LLC | 10 | $229 |
| Aimmune Therapeutics, Inc. | 11 | $222 |
| Madrigal Pharmaceuticals | 8 | $177 |
| Merz North America, Inc. | 1 | $158 |
| Regeneron Healthcare Solutions, Inc. | 6 | $137 |
| QOL Medical, LLC | 4 | $78 |
| Phathom Pharmaceuticals, Inc. | 5 | $55 |
| AstraZeneca | 2 | $53 |
| Ipsen Biopharmaceuticals, Inc | 3 | $50 |
| Ardelyx, Inc. | 2 | $27 |
| Biocon Biologics Inc | 1 | $20 |
| Mallinckrodt Hospital Products Inc. | 1 | $19 |
| Merck | 1 | $15 |
| Intercept Pharmaceuticals, Inc. | 1 | $15 |
| Avion Pharmaceuticals | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$1,766
- Creon$253
- Tremfya$229
- DAVINCI XI$200
- XEOMIN$158
- STELARA$112
How this compares
$4,947 in reported general payments places this provider in the 85th percentile of 370 medical providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 12 | $275 |
| Levothyroxine Sodium | 11 | $94 |
Paid to pharmacies, not to this prescriber.
Other medical in Tulsa
- Matthew DohlmanTulsa$39K
- Tara LinvilleTulsa$19K
- Debra OdomTulsa$17K
- Kristen HaunTulsa$15K
- Monica AbbottTulsa$11K
- Ryan ChoplinTulsa$10K
- Julie McArthurTulsa$9K
- Ashley BiggsTulsa$8K
- Erin JonesTulsa$6K
- Caroline ParkerTulsa$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.